Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VYNE Therapeutics (VYNE) Amortizatization of Intangibles (2017 - 2025)

VYNE Therapeutics (VYNE) has disclosed Amortizatization of Intangibles for 6 consecutive years, with -$214000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Amortizatization of Intangibles rose 65.26% year-over-year to -$214000.0, compared with a TTM value of -$1.6 million through Jun 2025, up 3.64%, and an annual FY2025 reading of -$778000.0, up 68.15% over the prior year.
  • Amortizatization of Intangibles was -$214000.0 for Q2 2025 at VYNE Therapeutics, up from -$324000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at -$214000.0 in Q2 2025 and bottomed at -$777000.0 in Q1 2024.
  • Average Amortizatization of Intangibles over 3 years is -$462285.7, with a median of -$506000.0 recorded in 2024.
  • The sharpest move saw Amortizatization of Intangibles tumbled 113.33% in 2024, then soared 65.26% in 2025.
  • Year by year, Amortizatization of Intangibles stood at -$255000.0 in 2023, then crashed by 113.33% to -$544000.0 in 2024, then skyrocketed by 60.66% to -$214000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for VYNE at -$214000.0 in Q2 2025, -$324000.0 in Q1 2025, and -$544000.0 in Q4 2024.